Underberg Sharon E. sold $6.1M of IDXX
Underberg Sharon E. (EVP, GC & Corporate Secretary) sold 8,906 shares of IDEXX LABORATORIES INC /DE (IDXX) at an average of $688.59 ($688.25–$690.02, $6.13M total) across 3 trades on 2026-11-04.
How this was made
The 30-second read
Why it matters
The disclosed sale may prompt short sellers and reduce bullish sentiment, but the effect is likely modest.
Market read
A senior officer's $6M share sale is a primary disclosure that could slightly weigh on IDXX's stock.
What to watch
Potential tax planning or pre-arranged liquidity needs not reflected in the filing.
Background
Form 4 filings disclose insider transactions; investors monitor them for signals about company outlook.
Ticker impact
EVP and General Counsel Sharon E. Underberg sold 8,906 shares for $6.13M, reducing her stake to 7,169 shares.
downward pressure as market prices in the insider sell
The sale is sizable for an insider and disclosed via a Form 4, a primary source, but the amount is modest relative to market cap.
Market effects
Minimal impact on the broader diagnostics sector; only a single insider transaction.
No regional effect beyond the company's share price.
Limited to investors tracking insider activity.
Counterpoint
The sale could be a routine portfolio rebalancing rather than a negative signal.
Key entities
- OfficerSharon E. Underberg
Executive Vice President, General Counsel & Corporate Secretary of IDEXX Laboratories.


